Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists

	Rheumatology
	The latest rheumatology news from News Medical

	Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide significant benefits for cardiovascular, kidney, liver, joint, and sleep-related diseases. These effects extend beyond weight loss, suggesting anti-inflammatory mechanisms with broad potential for managing chronic diseases.

	How targeted therapies are reshaping autoimmune disease treatment Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.

			Hendra Virus: An Emerging Zoonotic Threat in a Warming World Hendra virus is a highly lethal zoonotic pathogen primarily transmitted from flying foxes to horses and occasionally humans, with outbreaks linked to habitat loss and climate change. Prevention relies on integrated veterinary, ecological, and public health strategies, including vaccination, surveillance, and habitat restoration, to reduce spillover risk.

			Novel DNA plasmid therapy shows high success rate in treating chronic pain in dogs Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain demonstrating a 90% success rate.

			The role of cytokines in autoimmune disease progression and therapy Explore how cytokines contribute to autoimmune disease development and discover emerging therapies.

	Safeguarding your spinal health The first Saturday of May each year marks World Ankylosing Spondylitis (AS) Day, raising awareness of the 54 million patients globally living with spinal rigidity, morning stiffness and pain, bone spur proliferation, and even irreversible disability.

	Antibody-drug conjugates beyond oncology Learn how antibody-drug conjugates are advancing therapies for non-cancer conditions, unlocking new possibilities in precision medicine.

	Biological drug mechanisms in autoimmune diseases Understand the mechanisms behind biological drugs and how they help manage autoimmune conditions.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025